Literature DB >> 6613831

Hemodynamic effects of intravenous amiodarone in patients with depressed left ventricular function and recurrent ventricular tachycardia.

A Schwartz, E Shen, F Morady, K Gillespie, M Scheinman, K Chatterjee.   

Abstract

The systemic hemodynamic effects of intravenously administered amiodarone were evaluated in patients with depressed left ventricular function and recurrent sustained ventricular tachycardia. Heart rate decreased linearly up to 1 hour after amiodarone infusion (5 mg/kg). Cardiac index varied in a cubic fashion, diminishing at 10 minutes and returning to baseline by 60 minutes (p less than 0.05). Stroke work index also showed a similar decrease at 10 minutes, which was transient (p less than 0.005). These changes occurred without any significant change in systemic vascular resistance and with slight or no increase in pulmonary capillary wedge pressure, indicating a negative inotropic effect of amiodarone. The depression of left ventricular function in these patients, however, was mild and transient, and intravenously administered amiodarone was tolerated by the vast majority of patients. In two patients with overt heart failure and severely depressed left ventricular ejection fraction and marked hemodynamic abnormalities, profound hypotension occurred during amiodarone therapy; in such patients, therefore, hemodynamic monitoring is preferable. Limited data are available on the hemodynamic effects of orally administered amiodarone, but the determination of left ventricular ejection fraction by radionuclide ventriculography before and during long-term amiodarone administration has shown no reduction of function even in patients with severely reduced myocardial performance.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6613831     DOI: 10.1016/0002-8703(83)90007-8

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  13 in total

1.  Efficacy and safety of intravenous amiodarone in recent-onset atrial fibrillation: experience in patients admitted to a general internal medicine department.

Authors:  Y Kreiss; Y Sidi; H Gur
Journal:  Postgrad Med J       Date:  1999-05       Impact factor: 2.401

Review 2.  Risk-benefit assessment of amiodarone in the treatment of cardiac arrhythmias.

Authors:  P J Counihan; W J McKenna
Journal:  Drug Saf       Date:  1990 Jul-Aug       Impact factor: 5.606

3.  Amiodarone. Biochemical aspects and haemodynamic effects.

Authors:  J P Gagnol; C Devos; M Clinet; P Nokin
Journal:  Drugs       Date:  1985-03       Impact factor: 9.546

Review 4.  Acecainide (N-acetylprocainamide). A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cardiac arrhythmias.

Authors:  D W Harron; R N Brogden
Journal:  Drugs       Date:  1990-05       Impact factor: 9.546

5.  Haemodynamic effects of short term intravenous amiodarone for hypertrophic cardiomyopathy.

Authors:  A Branzi; C Rapezzi; P M Benenati; G Binetti; G Piovaccari; M Bacchi; R Roncuzzi; R Zannoli; B Magnani
Journal:  Br Heart J       Date:  1988-04

Review 6.  Amiodarone. An overview of its pharmacological properties, and review of its therapeutic use in cardiac arrhythmias.

Authors:  J Gill; R C Heel; A Fitton
Journal:  Drugs       Date:  1992-01       Impact factor: 9.546

7.  Class III antiarrhythmic drugs (amiodarone, bretylium and sotalol) on action potentials and membrane currents in rabbit sino-atrial node preparations.

Authors:  H Satoh
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-12       Impact factor: 3.000

8.  High-dosage continuous amiodarone therapy to treat new-onset supraventricular tachyarrhythmias in surgical intensive care patients: an observational study.

Authors:  Andreas J Mayr; Martin W Dünser; Nicole Ritsch; Werner Pajk; Barbara Friesenecker; Hans Knotzer; Hanno Ulmer; Volker Wenzel; Walter R Hasibeder
Journal:  Wien Klin Wochenschr       Date:  2004-05-31       Impact factor: 1.704

9.  Clinical, haemodynamic, and antiarrhythmic effects of long term treatment with amiodarone of patients in heart failure.

Authors:  J G Cleland; H J Dargie; I N Findlay; J T Wilson
Journal:  Br Heart J       Date:  1987-05

10.  Modeling of Amiodarone Effect on Heart Rate Control in Critically Ill Patients with Atrial Tachyarrhythmias.

Authors:  Joe-Elie Salem; Maria El-Aissaoui; Margaux Alazard; Jean-Sébastien Hulot; Nadia Aissaoui; Jean-Yves Le-Heuzey; Christian Funck-Brentano; Christophe Faisy; Saik Urien
Journal:  Clin Pharmacokinet       Date:  2016-08       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.